Please log in to see the full text of this API!

Ceftazidime

  • ATC: J01DA11
  • Use: Lorem 
  • Chemical name: Lorem ipsum dolor sit amet, consetetur sadipscing elitr, sed diam
  • Formula: Lorem ipsum dolor sit amet,
  • MW:546.59 g/mol
  • CAS-RN:72558-82-8
  • InChI Key:ORFOPKXBNMVMKC-DWVKKRMSSA-N
  • InChI:InChI=1S/C22H22N6O7S2/c1-​22(2,​20(33)​34)​35-​26-​13(12-​10-​37-​21(23)​24-​12)​16(29)​25-​14-​17(30)​28-​15(19(31)​32)​11(9-​36-​18(14)​28)​8-​27-​6-​4-​3-​5-​7-​27/h3-​7,​10,​14,​18H,​8-​9H2,​1-​2H3,​(H4-,​23,​24,​25,​29,​31,​32,​33,​34)/b26-​13-​/t14-,​18-​/m1/s1
  • EINECS:276-715-9
  • LD50:6300 mg/kg (M, i.v.); >20 g/kg (M, p.o.);
    5800 mg/kg (R, i.v.); >20 g/kg (R, p.o.)

Derivatives

    dihydrochloride

  • Use:
  • Formula: Lorem ipsum dolor sit amet,
  • MW:619.51 g/mol
  • CAS-RN:73547-70-3

Substance Classes

Synthesis Path

















Substances Referenced in Synthesis Path

CAS-RN Formula Chemical Name CAS Index Name
141-97-9 C6H10O3 acetoacetic acid ethyl ester Butanoic acid, 3-oxo-, ethyl ester
96752-43-1 C13H15Cl2N3O3S 7(R)-amino-3-(1-pyridiniomethyl)-3-cephem-4-carboxylic acid chloride monohydrochloride Pyridinium, 1-[(7-amino-2-carboxy-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-en-3-yl)methyl]-, chloride, monohydrochloride, (6R-trans)-
68672-66-2 C32H33N3O5S (Z)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)-2-(2-tritylaminothiazol-4-yl)acetic acid 4-Thiazoleacetic acid, α-[[2-(1,1-dimethylethoxy)-1,1-dimethyl-2-oxoethoxy]imino]-2-[(triphenylmethyl)amino]-, (Z)-
23877-12-5 C8H15BrO2 tert-butyl 2-bromo-2-methylpropionate Propanoic acid, 2-bromo-2-methyl-, 1,1-dimethylethyl ester
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem
Lorem Lorem Lorem Lorem

Trade Names

Country Trade Name Vendor Annotation
D Lorem Lorem Lorem ,1984
Lorem Lorem
Lorem ipsum
F Lorem Lorem
Lorem Lorem
GB Lorem Lorem
Lorem Lorem
I Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
Lorem Lorem
J Lorem Lorem
USA Lorem Lorem ,1985
(wfm = withdrawn from market)

Formulations

  • Loremipsumdolorsitamet,consetetursadipscingelitr,seddiamnonumy

References

    • DOS 9 999 999 (Glaxo; appl. 25.5.1979; GB-prior. 26.5.1978).
    • US 9 999 999 (Glaxo; 24.3.1981; GB-prior. 26.5.1978).
    • GB 9 999 999 (Glaxo; appl. 25.5.1979; GB-prior. 26.5.1978).
    • US 9 999 999 (Eli Lilly; 25.6.1985; prior. 27.12.1982, 3.2.1984).
  • intermediate IV:

    • US 9 999 999 (Glaxo; 5.2.1985; GB-prior. 13.11.1981).
  • acid chloride of IV:

    • EP 999 999 (Glaxo; appl. 28.4.1983; GB-prior. 29.4.1982).
  • intermediate V:

    • EP 999 999 (Eli Lilly; appl. 18.6.1984; USA-prior. 20.6.1983).
    • EP 99 999 (Glaxo; appl. 16.7.1982; GB-prior. 17.7.1981).
  • salts and crystal modifications:

  • crystalline dihydrochloride:

    • US 9 999 999 (Glaxo; 21.8.1984; GB-prior. 2.10.1979).
  • pentahydrate:

    • DOS 9 999 999 (Glaxo; appl. 1.10.1980; GB-prior. 2.10.1979).
    • GB 9 999 999 (Glaxo; appl. 1.10.1980; GB-prior. 2.10.1979).
    • US 9 999 999 (Glaxo; 11.5.1982; appl. 9.9.1980; GB-prior. 2.10.1979).
  • sesquihydrate:

    • DOS 9 999 999 (Hoechst; appl. 16.4.1983).
    • EP 999 999 (Hoechst; appl. 10.4.1984; D-prior. 16.4.1983).
  • anhydrous crystal modification:

    • DOS 9 999 999 (Hoechst; appl. 16.4.1983).
    • EP 999 999 (Hoechst; appl. 10.4.1984; D-prior. 16.4.1983).
  • pharmaceutical formulations:

    • DOS 9 999 999 (Glaxo; appl. 9.9.1983; GB-prior. 10.9.1982).
Cookie-Einstellungen